Cross-reactivity
Vaccinations
Vaccines
Vaccine Production
Arboviral Encephalitis
Pulmonary Tuberculosis IV
También podría leer
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Updated: Mar 27, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
Felicity Fitzgerald1, Shunmay Yeung2, Diana M Gibb3
1Infection, Immunity, Inflammation and Physiological Medicine, Institute of Child Health, University College London, London WC1N 1EH, UK; Kerry Town Ebola Treatment Centre, Save the Children International, Kerry Town, Sierra Leone.
No abstract available in PubMed .